EUVIMEDEUVIMED entdecken
Crossref

SYNERGISTIC ANTITUMOR EFFECT OF ASCORBIC ACID, LYSINE, PROLINE, AND EPIGALLOCATECHIN GALLATE ON HUMAN FIBROSARCOMA CELLS HT-1080

M. Waheed Roomi, Vadim Ivanov, Aleksandra Niedzwiecki, Matthias Rath

Annals of Cancer Research and Therapy · 2004

DOI: 10.4993/acrt.12.146 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Annals of Cancer Research and Therapy, 2004. Verfasst von M. Waheed Roomi und 3 weiteren Autor:innen. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 19 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Roomi, M. W., Ivanov, V., Niedzwiecki, A., & Rath, M. (2004). SYNERGISTIC ANTITUMOR EFFECT OF ASCORBIC ACID, LYSINE, PROLINE, AND EPIGALLOCATECHIN GALLATE ON HUMAN FIBROSARCOMA CELLS HT-1080. Annals of Cancer Research and Therapy. https://doi.org/10.4993/acrt.12.146

Vancouver

Roomi MW, Ivanov V, Niedzwiecki A, Rath M. SYNERGISTIC ANTITUMOR EFFECT OF ASCORBIC ACID, LYSINE, PROLINE, AND EPIGALLOCATECHIN GALLATE ON HUMAN FIBROSARCOMA CELLS HT-1080. Annals of Cancer Research and Therapy. 2004. doi:10.4993/acrt.12.146

BibTeX
@article{Roomi2004,
  author = {Roomi, M. Waheed and Ivanov, Vadim and Niedzwiecki, Aleksandra and Rath, Matthias},
  title = {SYNERGISTIC ANTITUMOR EFFECT OF ASCORBIC ACID, LYSINE, PROLINE, AND EPIGALLOCATECHIN GALLATE ON HUMAN FIBROSARCOMA CELLS HT-1080},
  journal = {Annals of Cancer Research and Therapy},
  year = {2004},
  doi = {10.4993/acrt.12.146}
}
Kostenlos starten →